| ECYT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ECYT shares outstanding history going back to 2/3/2011:
Also see: ECYT Market Cap History ECYT YTD Return |
| ECYT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ECYT Historical Shares Outstanding: +20.65% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ECYT Stock Price Chart |
| About Endocyte Inc |
| Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer. Co. uses drug conjugation technology to create therapeutics and companion imaging agents for personalized targeted therapies. Co.'s agents target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (PSMA) in prostate cancer. Co. has rights to develop and commercialize PSMA-617 agents, including the drug candidate known as 177Lu-PSMA-617, a radioligand therapeutic. Co. is also developing a therapeutic approach that involves the re-targeting of potent immune cells, called chimeric antigen receptor T-cells to fight cancer. We show 33 historical shares outstanding datapoints in our coverage of ECYT's shares outstanding history. Understanding the changing numbers of ECYT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ECYT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ECYT by allowing them to research ECYT shares outstanding history as well as any other stock in our coverage universe. |
| ECYT Current Stock Quote |
Quotes delayed 20 minutes  Free ECYT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ECYT Share Performance |
| Shares Outstanding Peers |
| Endocyte (ECYT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
EDAP Shares Outstanding History EDGE Shares Outstanding History EDIT Shares Outstanding History EGLT Shares Outstanding History EGRX Shares Outstanding History EHAB Shares Outstanding History EHC Shares Outstanding History EIDX Shares Outstanding History EIGR Shares Outstanding History EKSO Shares Outstanding History More Healthcare companies » |
ECYT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
